Haihua Ni

Title: Innovations by Haihua Ni in Topical Preparations

Introduction

Haihua Ni is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical innovations, particularly in the development of topical preparations. His work focuses on enhancing the efficacy of treatments for skin conditions caused by anti-tumor drugs.

Latest Patents

Haihua Ni holds a patent for a topical preparation containing vitamin K1 and its preparation method. This innovative formulation includes 0.01-5% of vitamin K1, 0.1-25% of a transdermal enhancer, and 70-99% of a matrix for the topical preparation. The transdermal enhancer is composed of urea, menthol, and oil in a specific mass ratio. This preparation is designed to treat moderate and severe skin toxicity related to epidermal growth factor receptor (EGFR) anti-tumor drugs. It effectively addresses conditions such as acne-like rash, pruritus, red swelling, dry skin, and mucositis, ensuring continued treatment with anti-EGFR targeting drugs.

Career Highlights

Haihua Ni is associated with Yangzijiang Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd. His work has been instrumental in advancing topical treatments that improve patient outcomes in oncology. His innovative approach to combining vitamin K1 with transdermal enhancers showcases his commitment to addressing complex medical challenges.

Collaborations

Haihua Ni has collaborated with notable colleagues, including Xinguo Jiang and Feng Jiang. Their combined expertise contributes to the development of effective pharmaceutical solutions.

Conclusion

Haihua Ni's contributions to the field of topical preparations highlight his innovative spirit and dedication to improving patient care. His patent for a vitamin K1-based topical preparation represents a significant advancement in treating skin toxicity from anti-tumor therapies.